Pfizer requests expansion of COVID-19 vaccine emergency use authorization to include adolescents and young teens

Pfizer today said it is seeking an amended emergency use authorization for its COVID-19 vaccine, requesting that the Food and Drug Administration allow its use for individuals between 12 and 15 years old.

The request follows last week’s release of late-trial data affirming the vaccine’s safety for that age group, along with 100% effectiveness in preventing COVID-19.